Pelikas Healthcare Private Limited

Wegovy (Semaglutide) 1.0mg FlexTouch solution for injection in pre-filled pen

Wegovy 1.0mg is a prescription only medicine indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of

• ≥ 30 kg/m2 (obesity), or
• ≥ 27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).

Wegovy (Semaglutide) 1.0mg FlexTouch solution for injection in pre-filled pen

Wegovy 1.0mg is a prescription only medicine indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of

• ≥ 30 kg/m2 (obesity), or
• ≥ 27 kg/m2 to <30 kg/m2 (overweight) in the presence of at least one weight-related comorbidity (e.g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus).

Empagliflozin which belongs to the group of medicines called Anti-diabetic drugs. It is used to manage type 2 diabetes in adults, that cannot be controlled by diet and exercise alone